ロード中...
Safety and efficacy of l‐lysine monohydrochloride and concentrated liquid l‐lysine (base) produced by fermentation using Corynebacterium glutamicum strains NRRL‐B‐67439 or NRRL B‐67535 for all animal species
The European Commission asked EFSA for an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of a l‐lysine monohydrochloride (HCl, minimum 98.5%) and of a concentrated liquid l‐lysine (base, minimum 50%) produced by genetically modified strains of Co...
保存先:
| 出版年: | EFSA J |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7008832/ https://ncbi.nlm.nih.gov/pubmed/32626174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2019.5886 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|